Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Farmers Insurance
Mallinckrodt
Argus Health
McKinsey
Fuji

Generated: June 26, 2019

DrugPatentWatch Database Preview

CEFTAZIDIME SODIUM - Generic Drug Details

Try a free trialSee Plans and Pricing

« Back to Dashboard

What are the generic sources for ceftazidime sodium and what is the scope of ceftazidime sodium patent protection?

Ceftazidime sodium is the generic ingredient in two branded drugs marketed by Baxter Hlthcare and Teligent, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for ceftazidime sodium. One supplier is listed for this compound.

Pharmacology for CEFTAZIDIME SODIUM
Synonyms for CEFTAZIDIME SODIUM
73547-61-2
AC1NUQMU
AKOS030627905
ceftazidime monosodium salt
Ceftazidime Sodium In Plastic Container
CHEBI:53675
CHEMBL1200768
CMC30V039K
Fortaz
Fortaz In Plastic Container
GR 20263 monosodium salt
Pyridinium, 1-(((6R,7R)-7-(((2Z)-(2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, monosodium salt
SCHEMBL1237408
sodium (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-methyl-1-oxido-1-oxopropan-2-yl)oxyiminoacetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxylatopropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxylatopropan-2-yl)oxy]imino}acetyl]amino}-3-(pyridinium-1-ylmethyl)-3,4-didehydrocepham-4-carboxylate
UNII-CMC30V039K

US Patents and Regulatory Information for CEFTAZIDIME SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare CEFTAZIDIME SODIUM IN PLASTIC CONTAINER ceftazidime sodium INJECTABLE;INJECTION 063221-003 Apr 29, 1993 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Baxter Hlthcare CEFTAZIDIME SODIUM IN PLASTIC CONTAINER ceftazidime sodium INJECTABLE;INJECTION 063221-001 Apr 29, 1993 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teligent FORTAZ IN PLASTIC CONTAINER ceftazidime sodium INJECTABLE;INJECTION 050634-003 Apr 28, 1989 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Teva
Accenture
Medtronic
Harvard Business School
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.